About Nanologica AB (publ)
Nanologica manufactures and sells nanoporous silica particles for applications within life science. A proprietary production method enables the company to create world-class products by precisely controlling the shape, size, porosity, and surface properties of silica particles. The company provides high-quality silica products used in the purification of peptide drugs. These products can contribute to lower costs and higher production for pharmaceutical manufacturers, which increases the availability of cost-effective medicines and gives more people around the world access to vital treatment for diabetes and obesity. Nanologica is headquartered in Södertälje and Nanologica's share (NICA) has been listed for trading on Nasdaq Stockholm Main Market since 2022. For further information, please visit www.nanologica.com.